Inflammatory cytokine gene expression

Inflammatory cytokine gene expression is the biological process involving the transcription and translation of genes that encode pro-inflammatory signaling proteins, such as TNF-alpha, IL-1 beta, and IL-6 (Source: NIH, PubMed). This process is a critical component of the innate and adaptive immune responses, typically triggered by pattern recognition receptors (PRRs) detecting pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (Source: StatPearls). Key intracellular signaling pathways, notably the NF-kappaB, MAPK, and JAK/STAT pathways, converge on the nucleus to initiate the production of these mediators (Source: Nature Reviews Immunology). Chronic or excessive expression of these genes is central to the pathogenesis of various inflammatory diseases, including rheumatoid arthritis, Crohn's disease, and systemic lupus erythematosus (Source: PubMed). Therapeutic strategies to modulate this expression include the use of corticosteroids, which act as transcription factor modulators, and various kinase inhibitors that interrupt the signaling required for gene activation (Source: PMC). Monitoring the levels of these cytokines or their mRNA serves as a critical biomarker for assessing disease severity and treatment response in clinical practice (Source: PubMed).

Other names

Pro-inflammatory cytokine productionCytokine gene transcriptionInflammatory mediator expressionCytokine mRNA expression

Suppression of gene transcription through the modulation of nuclear receptors (e.g., glucocorticoid receptors) or the inhibition of upstream signaling kinases (e.g., JAK, MAPK) that activate transcription factors like NF-kappaB.